Effectiveness of a prevention program for refugees in the Netherlands
| ISRCTN | ISRCTN18019972 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN18019972 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Protocol serial number | 60-63605-98-207 |
| Sponsor | GZA Healthcare |
| Funder | ZonMw |
- Submission date
- 20/06/2024
- Registration date
- 20/06/2024
- Last edited
- 20/06/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Plain English summary of protocol
Background and study aims
Few studies have explored the effects of mental health and psychosocial support programs among refugees who are residing at asylum centers. The aim of this study was to assess the impact and feasibility of a positive psychology intervention, BAMBOO, among refugees temporarily residing at asylum centers in the Netherlands.
Who can participate?
Residents of asylum centers, aged 18 years or older.
What does the study involve?
Since January 2020, BAMBOO has been available at all asylum seekers centers in the Netherlands. The program is a multicomponent PPI that consists of five weekly two-hour sessions. Each session and its activities were centered around a specific topic, namely: (i) resilience; (ii) emotions; (iii) strengths; (iv) gratitude; and (v) goal setting. The program has versions for children, youths, and adults. The current study collected data among at 35 refugees centers during programs that were conducted for adults.
What are the possible benefits and risks of participating?
Expected benefits of the program are increased resilience an mental wellbeing. Data collection during the trial may be associated with mild emotional discomfort due to the discussion of sensitive topics. Adverse effects are not expected
Where is the study run from?
GZA Healthcare (Netherlands)
When is the study starting and how long is it expected to run for?
March 2020 to February 2023
Who is funding the study?
ZonMW (Subsidy round Care and support for refugees in the Netherlands - practice project. Dossier number: 60-63605-98-207)
Who is the main contact?
Dr Tom Hendriks, T.Hendriks_2@tilburguniversity.edu
Contact information
Public, Scientific, Principal investigator
RIJZERTLAAN 292
Den Bosch
5223 JR
Netherlands
 ORCID ID |
0000-0002-5220-0640 |
|---|---|
| Phone | +31 629363866 |
| T.Hendriks_2@tilburguniversity.edu |
Study information
| Primary study design | Observational |
|---|---|
| Study design | One-group pretest–posttest (O1–X–O2) design |
| Secondary study design | Cohort study |
| Participant information sheet | 45665 BAMBOO Q PIS.pdf |
| Scientific title | Effectiveness of a mental health and psychosocial support program for refugees residing at an asylum center |
| Study acronym | BAMBOO 1.0 |
| Study objectives | Few studies have explored the effects of mental health and psychosocial support programs among refugees who are residing at asylum centers. The aim of this study was to assess the impact and feasibility of a positive psychology intervention, BAMBOO, among refugees temporarily residing at asylum centers in the Netherlands |
| Ethics approval(s) |
Approved 17/01/2021, Ethics Review Board (ERB), Tilburg University (Warandelaan 2, Tilburg, 5000 LE, Netherlands; +31 13 466 91 11; erb@tilburguniversity.edu), ref: TSB RP381 |
| Health condition(s) or problem(s) studied | Prevention to increase resilience and wellbeing among refugees living at refugee centers in the Netherlands. |
| Intervention | This study measures changes in resilience and wellbeing among participants of the BAMBOO program, a mental health care prevention that consists of five weekly two-hour sessions. BAMBOO is a multi-component positive psychology intervention. Each session and its activities are centered around a specific topic, namely: (i) resilience; (ii) emotions; (iii) strengths; (iv) gratitude; and (v) goal setting. Groups in the BAMBOO ideally comprised eight to 10 people. Self report questionnaires are collected at pre-test assessment and post-test assessment. There is no control group |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
Resilience is measured using the Connor Davidson Resilience Scale (CD-RISC-10) at pre-and post-test assessment |
| Key secondary outcome measure(s) |
1. Well-being is measured using the Visual Analogue Happiness Scale (VAHS), and the International Positive And Negative Affect Schedule (IPANAS) at pre-and post-test assessment. |
| Completion date | 28/02/2023 |
Eligibility
| Participant type(s) | Resident |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 65 Years |
| Sex | All |
| Target sample size at registration | 225 |
| Total final enrolment | 243 |
| Key inclusion criteria | 1. 18 years and older 2. Residing at an asylum center 3. Able to follow the program for five consecutive weeks |
| Key exclusion criteria | Refugees who are in treatment for severe psychological or psychiatric problems |
| Date of first enrolment | 01/06/2021 |
| Date of final enrolment | 28/02/2023 |
Locations
Countries of recruitment
- Netherlands
Study participating centres
Herculesplein 28
Utrecht
3584 AA
Netherlands
Katwijk aan Zee
2223 LG
Netherlands
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan summary | Available on request |
| IPD sharing plan | The dataset generated and analysed during the current study is stored on a secured webserver of GZA healthcare. Data from participants has been anonymised. The data was collected among asylum seekers. Some refugees fled from countries where they were persecuted for political and /or religious reasons. Given the vulnerability of our population data cannot be stored in a non publicly available repository and will only be shared after request and approval of the requesting party. All participants were informed about the intended goal of the program. Participation in the program and the study was voluntary. Participants were informed that they could discontinue the program at any time without any negative consequences. All participants signed an informed consent form before joining. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | 20/06/2024 | No | Yes | ||
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Study website | Study website | 11/11/2025 | 11/11/2025 | No | Yes |
Additional files
- 45665 BAMBOO Q PIS.pdf
- Participant information sheet
Editorial Notes
20/06/2024: Trial's existence confirmed by Ethics Review Board (ERB), Tilburg University
